Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 65862-818

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tenofovir Disoproxil Fumarate (NDC 65862-818). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (150 mg (30 Tablets Bottle))

Label for Tenofovir Disoproxil Fumarate Tablets, 150 mg film-coated tablets manufactured by Aurobindo Pharma Limited. The label specifies the product is for prescription use only, contains 30 tablets, and includes storage instructions and distributor information for Aurobindo Pharma USA, Inc. A barcode and NDC 65862-818-30 are also visible.*

FDA Label Image

Package Label-principal Display Panel (200 mg (30 Tablets Bottle))

Box packaging label for Tenofovir Disoproxil Fumarate Tablets 150 mg film-coated tablets by Aurobindo Pharma Limited. The label indicates 30 unit-dose tablets (3 x 10) with NDC 65862-818-03. The design features blue and teal color accents with the Aurobindo logo visible.*

FDA Label Image

Package Label-principal Display Panel (250 mg (30 Tablets Bottle))

Label for Tenofovir Disoproxil Fumarate Tablets 200 mg, film-coated, containing 30 tablets. Produced by Aurobindo Pharma Limited and distributed by Aurobindo Pharma USA, Inc. The label includes storage instructions, dosage mention, NDC 65862-819-30, and origin stated as Made in India.*

FDA Label Image

Package Label-principal Display Panel (300 mg (30 Tablets Bottle))

Packaging label for Tenofovir Disoproxil Fumarate Tablets 200 mg, film-coated tablets in unit-dose packaging of 30 tablets (3 x 10). Label shows the brander Aurobindo Pharma Limited, NDC 65862-819-03, and dosage strength prominently. The label includes directions indicating prescription use only and specifies the tablet form and quantity.*

FDA Label Image

Tenofovir Fig5

Label for Tenofovir Disoproxil Fumarate Tablets, 250 mg, film-coated, containing 30 tablets. The label indicates the product is distributed by Aurobindo Pharma USA, Inc. It includes storage instructions and a note that the container should be kept tightly closed. Manufactured in India, the label features the NDC 65862-820-30 and branding for Aurobindo Pharma Limited.*

FDA Label Image

Tenofovir Fig6

Packaging label for Tenofovir Disoproxil Fumarate Tablets 250 mg, film-coated tablets, manufactured by Aurobindo Pharma Limited. The label states Rx only and shows a package size of 30 unit-dose tablets (3 strips of 10). The product NDC is 65862-820-03. The label includes a barcode and information about the tablet strength and quantity.*

FDA Label Image

Tenofovir Fig7

Label for Tenofovir Disoproxil Fumarate Tablets 300 mg, film-coated tablets for prescription use. The label shows the NDC number 65862-421-30, manufactured by Aurobindo Pharma Limited and distributed by Aurobindo Pharma USA, Inc. The label includes storage instructions, dosage notes, and a 30 tablet count.*

FDA Label Image

Tenofovir Structure (Tenofovir Str)

Chemical structure of Tenofovir Disoproxil Fumarate showing its molecular components and arrangement, including the Tenofovir moiety and fumarate component depicted separately.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.